MEM Rights Issue Prospectus shortfall 26/03/19 PRICE SENSITIVE Share MEM Rights Issue Prospectus 01/03/19 PRICE SENSITIVE Share MEM Half Yearly Report and Accounts 28/02/19 PRICE SENSITIVE Share MEM Entitlement issue and dual listing 27/02/19 PRICE SENSITIVE Share MEM Trading Halt 25/02/19 PRICE SENSITIVE Share MEM Response to ASX aware query 23/10/18 PRICE SENSITIVE Share MEM Response to ASX price query 18/10/18 PRICE SENSITIVE Share MEM Pause in trading 18/10/18 PRICE SENSITIVE Share MEM Collaborative Agreement with Monash IVF Group 18/09/18 PRICE SENSITIVE Share MEM Preliminary Final Report 24/08/18 PRICE SENSITIVE Share MEM Proposed share consolidaiton 03/07/18 PRICE SENSITIVE download Created with Sketch. 156.25KB Share MEM Memphasys raises $1m via a strategic investment 25/05/18 PRICE SENSITIVE download Created with Sketch. 243.14KB Share MEM Felix device development update 03/05/18 PRICE SENSITIVE Share MEM Appendix 4D - December 2017 Half year Financial Accounts 23/02/18 PRICE SENSITIVE Share MEM Legal action with Platinum Road / Bridge Road Capital 13/02/18 PRICE SENSITIVE Share MEM $400,000 Special Grant received from the NSW Medical Devices 22/12/17 PRICE SENSITIVE Share MEM MEM Non-Renounceable Rights Issue Offer 28/11/17 PRICE SENSITIVE Share MEM Rights Offer Cleaning Notice 28/11/17 PRICE SENSITIVE Share MEM $400,000 special grant offer from NSW Medical Devices Fund 24/11/17 PRICE SENSITIVE Share MEM $3.75M Capital Raising to Accelerate Dev of Felix Device 21/11/17 PRICE SENSITIVE Share MEM Advanced development of Felix device supported by R&D rebate 10/10/17 PRICE SENSITIVE Share MEM Adjusting amendment to Appendix 4E 13/09/17 PRICE SENSITIVE Share MEM Appendix 4E Preliminary Final Report 31/08/17 PRICE SENSITIVE Share MEM Correction to Outcome of Litigation 28/07/17 PRICE SENSITIVE Share MEM Outcome of Litigation 27/07/17 PRICE SENSITIVE Share MEM Trading Halt 25/07/17 PRICE SENSITIVE Share MEM Felix Project development update 13/07/17 PRICE SENSITIVE Share MEM Extension of Director line of credit 03/07/17 PRICE SENSITIVE Share MEM SpermSep device development update 29/06/17 PRICE SENSITIVE Share MEM Update on SpermSep Device Development 18/05/17 PRICE SENSITIVE Share MEM Completes sale of Gels business and Crescendas Loan clarific 06/04/17 PRICE SENSITIVE Share MEM Commence next phase of SpermSep Development and new funding 04/04/17 PRICE SENSITIVE Share MEM Loan from Crescendas Projects and PrIME legal dispute update 02/03/17 PRICE SENSITIVE Share MEM Appendix 4D and Half Year Financial Accounts 28/02/17 PRICE SENSITIVE Share MEM Funding Update - loan and line of credit 23/02/17 PRICE SENSITIVE Share MEM Update on Dispute Resolution Process 17/02/17 PRICE SENSITIVE Share MEM Statutory Demand To Be Set Aside 15/02/17 PRICE SENSITIVE Share MEM Memphasys' Capital Raising Review 16/12/16 PRICE SENSITIVE Share MEM Capital Raising 12/12/16 PRICE SENSITIVE Share MEM STATEMENT OF CLAIM FROM TRANSOCEAN SECURITIES 21/11/16 PRICE SENSITIVE Share MEM UPDATE ON LITIGATION AGAINST PRIME 11/11/16 PRICE SENSITIVE Share MEM Capital Raising and New Corporate Advisor-MEM.AX 20/09/16 PRICE SENSITIVE Share MEM Trading Halt-MEM.AX 16/09/16 PRICE SENSITIVE Share MEM Letter of Demand from PrIME and Manukan re A-Bio Debt Repaym-MEM.AX 12/09/16 PRICE SENSITIVE Share MEM Appendix 4E & FY2016 Preliminary Final Report-MEM.AX 31/08/16 PRICE SENSITIVE Share MEM Extended Date for A-Bio Debt Repayment-NSP.AX 02/06/16 PRICE SENSITIVE Share MEM PrIME Capital Raising-NSP.AX 16/05/16 PRICE SENSITIVE Share MEM Reinstatement to Official Quotation-NSP.AX 02/05/16 PRICE SENSITIVE Share MEM Continuing Negotiations on sale of B Class shares in PrIME-NSP.AX 02/05/16 PRICE SENSITIVE Share MEM Suspension from Official Quotation-NSP.AX 26/04/16 PRICE SENSITIVE Share MEM Trading Halt-NSP.AX 21/04/16 PRICE SENSITIVE Share MEM Non-Renounceable Entitlement Issue Closure 15/03/16 PRICE SENSITIVE Share MEM Replacement Prospectus 26/02/16 PRICE SENSITIVE Share MEM Appendix 4D and Half Year Report December 2015 26/02/16 PRICE SENSITIVE Share MEM University of Newcastle Agreement 22/02/16 PRICE SENSITIVE Share MEM Non-renounceable Entitlement Offer 16/02/16 PRICE SENSITIVE Share MEM Non-Renounceable Issue 16/02/16 PRICE SENSITIVE Share MEM Entitlement Offer and Appendix 3B 15/02/16 PRICE SENSITIVE Share MEM Private placement 11/01/16 PRICE SENSITIVE Share MEM Trading Halt 07/01/16 PRICE SENSITIVE Share MEM Loan from A Goodall 18/11/15 PRICE SENSITIVE Share MEM Settlement of dispute with former Managing Director 13/11/15 PRICE SENSITIVE Share MEM Half Year Accounts 01/09/15 PRICE SENSITIVE Share MEM START OF IN-VITRO CLINICAL TRIAL AT MONASH IVF 10/08/15 PRICE SENSITIVE Share MEM Security Purchase Plan 10/08/15 PRICE SENSITIVE Share MEM Proposed Sale of Interest in PrIME Biologics Pte Limited 23/07/15 PRICE SENSITIVE Share MEM ASIC Investigation of NuSep Concluded 09/07/15 PRICE SENSITIVE Share MEM Receipt of Short Term Loan and Market Update 29/06/15 PRICE SENSITIVE Share MEM NuSep Receives Short Term Loan from Singapore Company 10/04/15 PRICE SENSITIVE Share MEM Half Yearly Report and Accounts 02/03/15 PRICE SENSITIVE Share MEM Enforceable Undertaking 18/12/14 PRICE SENSITIVE Share MEM R&D Tax Refund 18/12/14 PRICE SENSITIVE Share MEM Supply of Membranes to Prime Biologics Pte Ltd 04/11/14 PRICE SENSITIVE Share MEM NuSep signs Heads of Agreement with Minitub GmbH 04/11/14 PRICE SENSITIVE Share MEM Market Update 08/10/14 PRICE SENSITIVE Share MEM Appendix 4E 01/09/14 PRICE SENSITIVE Share MEM Payment Renegotiation for Singapore Processing Facility 05/06/14 PRICE SENSITIVE Share MEM Off Market Share Transaction 12/05/14 PRICE SENSITIVE Share MEM Investment Transaction For PrIME Biologics Private Limited 09/05/14 PRICE SENSITIVE Share MEM Trading Halt 07/05/14 PRICE SENSITIVE Share MEM Loan Facilities 03/03/14 PRICE SENSITIVE Share MEM Half Yearly Report and Accounts 28/02/14 PRICE SENSITIVE Share MEM Placement 19/02/14 PRICE SENSITIVE Share MEM Change in Chief Executive Officer 11/02/14 PRICE SENSITIVE Share MEM Proposed Issue of Share Options 24/01/14 PRICE SENSITIVE Share MEM NuSep Working Capital Advance 20/01/14 PRICE SENSITIVE Share MEM PrIME receives Xeraya Board conditional approval for Funding 24/12/13 PRICE SENSITIVE Share MEM PrIME signs Non Binding Funding Term Sheet 29/10/13 PRICE SENSITIVE Share MEM NuSep Receives $1.6m R&D Tax Refund 08/10/13 PRICE SENSITIVE Share MEM NuSep announces 30 June 2013 Full Year Results 30/08/13 PRICE SENSITIVE Share MEM NuSep lodges $1.6m R&D Tax Refund 23/08/13 PRICE SENSITIVE Share MEM Update on PrIME LOI Funding 29/07/13 PRICE SENSITIVE Share MEM Funding Update & SPP Announcement 22/07/13 PRICE SENSITIVE Share MEM NuSep Announces Long Term Debt Management 09/07/13 PRICE SENSITIVE Share MEM PrIME Receives Plasma Importation License 11/06/13 PRICE SENSITIVE Share MEM NuSep Signs LOI to Fund PrIME 03/06/13 PRICE SENSITIVE Share MEM First PrIME Franchise Proposal 30/05/13 PRICE SENSITIVE Share MEM Dengue Diagnostic & Therapeutic - New Application of PrIME 23/05/13 PRICE SENSITIVE Share MEM NuSep Update 20/05/13 PRICE SENSITIVE Share MEM PrIME Update 15/05/13 PRICE SENSITIVE Share
